Implementation and Deliver of Lenacapavir for PrEP in a Community Pharmacy Setting

Running, not enrolling · Phase 4

Conditions studied: HIV

In brief

This is an open-label, single center study to evaluate implementation of a pharmacist-managed delivery of L4P in a community pharmacy setting and the impact of twice-yearly vs. quarterly PrEP visits on STI rates.

Key facts

Study ID

NCT07210125

Run by

Kelley-Ross & Associates, Inc.

People needed

75

Starts

2025-09-16

Expected to finish

2027-06-30

Last updated by the study team

2026-04-02

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• 18 years of age or older at the time of screening
• weight greater than or equal to 35kg
• HIV-negative status
• Willing to provide informed consent and undergo all required study procedures

You may not qualify if…

• Unknown or positive HIV status
• Coadministration of drugs that significantly decreases lenacapavir concentrations according to the FDA package insert
• Any participant that do not meet criteria for management under the CDTA

Where it is running

• Kelley-Ross Pharmacy — Seattle, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.